Ken Griffin Meridian Bioscience Inc Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $3.91 Million - $4.2 Million	125,670 New	125,670 $4.17 Million
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $672,389 - $907,069	33,670 Added 281.03%	45,651 $1.19 Million
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $953,298 - $1.18 Million	-54,599 Reduced 82.01%	11,981 $244,000
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $444,472 - $576,405	-25,618 Reduced 27.79%	66,580 $1.28 Million
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $603,082 - $948,323	-33,486 Reduced 26.64%	92,198 $2.04 Million
Q1 2021 May 17, 2021	SELL	$19.76 - $29.89 $634,592 - $959,917	-32,115 Reduced 20.35%	125,684 $3.3 Million
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $2.18 Million - $3 Million	138,350 Added 711.35%	157,799 $2.95 Million
Q3 2020 Nov 16, 2020	SELL	$13.54 - $26.41 $668,496 - $1.3 Million	-49,372 Reduced 71.74%	19,449 $330,000
Q2 2020 Aug 14, 2020	SELL	$7.84 - $23.29 $325,900 - $968,142	-41,569 Reduced 37.66%	68,821 $1.6 Million
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $554,521 - $1.14 Million	99,555 Added 918.83%	110,390 $927,000
Q4 2019 Feb 14, 2020	SELL	$7.9 - $10.14 $618,767 - $794,215	-78,325 Reduced 87.85%	10,835 $106,000
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $487,853 - $638,944	-53,201 Reduced 37.37%	89,160 $846,000
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $583,287 - $943,553	-53,611 Reduced 27.36%	142,361 $1.69 Million
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $171,633 - $194,872	-11,066 Reduced 5.34%	195,972 $0
Q4 2018 Feb 14, 2019	BUY	$14.52 - $19.72 $372,176 - $505,463	25,632 Added 14.13%	207,038 $3.59 Million
Q3 2018 Nov 13, 2018	SELL	$14.85 - $16.35 $2.11 Million - $2.32 Million	-141,909 Reduced 43.89%	181,406 $0
Q2 2018 Aug 10, 2018	BUY	$13.8 - $16.8 $3.75 Million - $4.56 Million	271,472 Added 523.64%	323,315 $0
Q1 2018 May 11, 2018	SELL	$13.8 - $16.2 $147,273 - $172,886	-10,672 Reduced 17.07%	51,843 $736,000
Q4 2017 Feb 09, 2018	SELL	$13.55 - $15.8 $899,232 - $1.05 Million	-66,364 Reduced 51.49%	62,515 $875,000
Q3 2017 Nov 09, 2017	BUY	$13.45 - $14.35 $1.73 Million - $1.85 Million	128,879	128,879 $1.84 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account